Anti-Inosine triphosphate pyrophosphatase抗體[EPR8779]-抗體-抗體-生物在線
深圳市宇德立生物科技有限公司
Anti-Inosine triphosphate pyrophosphatase抗體[EPR8779]

Anti-Inosine triphosphate pyrophosphatase抗體[EPR8779]

商家詢價

產品名稱: Anti-Inosine triphosphate pyrophosphatase抗體[EPR8779]

英文名稱: C20orf37 antibody dJ794I6.3 antibody HLC14-06-P antibody Inosine triphosphatase (nucleoside triphosphate pyrophosphatase) antibody Inosine triphosphat

產品編號: ab150420

產品價格: null

產品產地: 英國

品牌商標: abcam

更新時間: null

使用范圍:

深圳市宇德立生物科技有限公司
  • 聯系人 :
  • 地址 : 深圳市寶安區西鄉寶民二路賢基大廈4E
  • 郵編 :
  • 所在區域 : 廣東
  • 電話 : 133****4454 點擊查看
  • 傳真 : 點擊查看
  • 郵箱 : 1484332550@qq.com

?

  • 經測試應用WB,?Flow Cytmore details
  • 種屬反應性
    與反應:?Mouse, Rat, Human
  • 免疫原

    Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) (internal sequence)

  • 陽性對照
    • Jurkat, HepG2, HeLa and K562 cell lysates; permeabilized HeLa cells.
  • 常規說明

    This product is a recombinant rabbit monoclonal antibody.

    Produced using Abcam’s RabMAb??technology. RabMAb??technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.

性能

應用

Our?Abpromise guarantee?covers the use of?ab150420?in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

應用 Abreviews 說明
WB ? 1/1000 - 1/10000. Predicted molecular weight: 21 kDa.
Flow Cyt ? 1/10 - 1/100.?ab172730-Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.
  • 應用說明Is unsuitable for ICC,IHC-P or IP.

靶標

  • 功能Hydrolyzes ITP and dITP to their respective monophosphate derivatives. Xanthosine 5'-triphosphate (XTP) is also a potential substrate. May be the major enzyme responsible for regulating ITP concentration in cells.
  • 組織特異性Ubiquitous. Highly expressed in heart, liver, sex glands, thyroid and adrenal gland.
  • 疾病相關Defects in ITPA are the cause of inosine triphosphate pyrophosphohydrolase deficiency (ITPA deficiency) [MIM:147520]. It is a common inherited trait characterized by the abnormal accumulation of inosine triphosphate (ITP) in erythrocytes and also leukocytes and fibroblasts. The pathological consequences of ITPA deficiency, if any, are unknown. However, it might have pharmacogenomic implications and be related to increased drug toxicity of purine analog drugs. Three different human populations have been reported with respect to their ITPase activity: high, mean (25% of high) and low activity. The variant Thr-32 is associated with complete loss of enzyme activity, may be by altering the local secondary structure of the protein. Heterozygotes for this polymorphism have 22.5% of the control activity: this is consistent with a dimeric structure of the enzyme.
  • 序列相似性Belongs to the HAM1 NTPase family.
  • 細胞定位Cytoplasm.
  • Information by UniProt
  • 數據庫鏈接
  • 別名
    • C20orf37 antibody
    • dJ794I6.3 antibody
    • HLC14-06-P antibody
    see all

Anti-Inosine triphosphate pyrophosphatase antibody [EPR8779] 圖像

  • All lanes :?Anti-Inosine triphosphate pyrophosphatase antibody [EPR8779] (ab150420) at 1/1000 dilution

    Lane 1 :?Jurkat cell lysate
    Lane 2 :?HepG2 cell lysate
    Lane 3 :?HeLa cell lysate
    Lane 4 :?K562 cell lysate

    Lysates/proteins at 10 μg per lane.


    Predicted band size :?21 kDa
  • Flow cytometric analysis of permeabilized HeLa cells labeling Inosine triphosphate pyrophosphatase with ab150420 at 1/10 dilution(red) comapred with a rabbit IgG negative control (green).